Breast Cancer Screening

  • Steven Rockoff
  • Joseph D. Calandra


Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. Approximately one out of every eight American women will be diagnosed with breast cancer in their lifetime. This chapter summarizes key concepts for breast cancer screening, with an emphasis on imaging. The breast cancer screening recommendations from the most prominent medical societies are presented and summarized. Screening recommendations are broadly divided for women at average risk, at moderate risk, and at high risk for developing breast cancer in their lifetime. Guidance is provided as to what risk factors may place a woman into one of these categories. Current concepts regarding cancer screening in women with dense breasts are also discussed, as well as an overview of what can be expected when diagnostic imaging is pursued to evaluate a patient’s symptom.


Breast cancer Breast screening Mammography MRI Ultrasound Prevention High risk 


  1. 1.
    Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute; 2012.Google Scholar
  2. 2.
    Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. preventive services task force. Ann Intern Med. 2009;151(10):727–37. W237–42.CrossRefGoogle Scholar
  3. 3.
    American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.Google Scholar
  4. 4.
    Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57.CrossRefGoogle Scholar
  5. 5.
    Siu AL, on behalf of the U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:279–96.CrossRefGoogle Scholar
  6. 6.
    American College of Obstetricians and Gynecologists. Frequently asked questions: mammography and other screening tests for breast problems; 2016. Retrieved Feb 2016.
  7. 7.
    Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.CrossRefGoogle Scholar
  8. 8.
    American College of Obstetricians and Gynecologists. ACOG statement on revised American Cancer Society recommendations on breast cancer screening; 2015. Retrieved Feb 2016.
  9. 9.
    Ichikawa LE, Barlow WE, Anderson ML, et al. Time trends in radiologists’ interpretive performance at screening mammography from the community-based breast cancer surveillance consortium, 1996–2004. Radiology. 2010;256(1):74–82.CrossRefGoogle Scholar
  10. 10.
    American Cancer Society. Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society; 2015. Retrieved Feb 2016.Google Scholar
  11. 11.
    Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474–82.PubMedPubMedCentralGoogle Scholar
  12. 12.
    National Cancer Institute. Breast cancer risk assessment tool; 2011. Retrieved Feb 2016.
  13. 13.
    American Cancer Society. American Cancer Society recommendations for early breast cancer detection in women without breast symptoms; 2015. Retrieved Feb 2016.
  14. 14.
    Mainiero MB, Lourenco A, Mahoney MC, et al. American College of Radiology appropriateness criteria for breast cancer screening; 2012. Retrieved Feb 2016.
  15. 15.
    National Comprehensive Cancer Network. Breast cancer screening and diagnosis, Version 1.2015; 2015. Retrieved Feb 2016.
  16. 16.
    Tosteson AN, Fryback DG, Hammond CS, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014;174(6):954–61.CrossRefGoogle Scholar
  17. 17.
    Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.CrossRefGoogle Scholar
  18. 18.
    Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011;196(2):W112–6.CrossRefGoogle Scholar
  19. 19.
    The Henry J. Kaiser Family Foundation. Preventive services covered by Private Health Plans under the Affordable Care Act; 2015. Retrieved Feb 2016.
  20. 20.
    Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.CrossRefGoogle Scholar
  21. 21.
    Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292(11):1317–25.CrossRefGoogle Scholar
  22. 22.
    Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230(1):29–41.CrossRefGoogle Scholar
  23. 23.
    Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9):807–16.CrossRefGoogle Scholar
  24. 24.
    Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165–75.CrossRefGoogle Scholar
  25. 25.
    Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.CrossRefGoogle Scholar
  26. 26.
    Sprague BL, Stout NK, Schechter C, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015;162(3):157–66.CrossRefGoogle Scholar
  27. 27.
    Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.CrossRefGoogle Scholar
  28. 28.
    Brem RF, Tabár L, Duffy SW, et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight study. Radiology. 2015;274(3):663–73.CrossRefGoogle Scholar
  29. 29.
    D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA, et al. ACR BI-RADS atlas, breast imaging reporting and data system. Reston: American College of Radiology; 2013.Google Scholar
  30. 30.
    Schell MJ, Yankaskas BC, Ballard-Barbash R, et al. Evidence-based target recall rates for screening mammography. Radiology. 2007;243(3):681–9.CrossRefGoogle Scholar
  31. 31.
    Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology. 2006;241(1):55–66.CrossRefGoogle Scholar
  32. 32.
    Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer. 2000;89(12):2538–46.CrossRefGoogle Scholar
  33. 33.
    Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004;231(3):813–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Steven Rockoff
    • 1
  • Joseph D. Calandra
    • 1
  1. 1.Department of RadiologyPresence Saint Francis HospitalEvanstonUSA

Personalised recommendations